Notice of Correction to PA-17-109 "Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21)"

Notice Number: NOT-CA-17-062

Key Dates
Release Date:   May 10, 2017

Related Announcements
PA-17-109

Issued by
National Cancer Institute (NCI))
National Institute on Aging (NIA)

Purpose

The purpose of this Notice is to correct PA-17-109 "Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21)." The correction more accurately reflects the U. S. Preventive Services Task Force (USPSTF) recommendation by changing the upper age limit for routine breast cancer screening in average risk women from 74 years to 75 years. Therefore, overscreening, for the purposes of this announcement, is routine screening of women aged 75 years and older.

The following "Key Definitions" subsection has been corrected (in italics):

Part 2. Full Text of Announcement, Section I. Funding Opportunity Description

Currently reads
Key Definitions for the context of this FOA:

Overscreening: Based on the United States Preventive Services Task Force (USPSTF) evidence-based guidelines for breast, cervical and colorectal cancers, overscreening will be defined as the following:

  • Routine breast cancer screening in average-risk women aged 74 years and older.
  • Any cervical cancer screening in average-risk women aged 65 years and older.
  • Routine colorectal cancer screening in men and women aged 75 years and older.
  • Any colorectal screening in men and women aged 85 years or older.

Modified to read (in italics)
Key Definitions for the context of this FOA:

Overscreening: Based on the United States Preventive Services Task Force (USPSTF) evidence-based guidelines for breast, cervical and colorectal cancers, overscreening will be defined as the following:

  • Routine breast cancer screening in average-risk women aged 75 years and older.
  • Any cervical cancer screening in average-risk women aged 65 years and older.
  • Routine colorectal cancer screening in men and women aged 75 years and older.
  • Any colorectal screening in men and women aged 85 years or older.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Erica S. Breslau, Ph.D., M.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-6773
Email: breslaue@mail.nih.gov

Marcel E. Salive, M.D., M.P.H.
National Institute on Aging (NIA)
Telephone: 301-496-5278
Email: saliveme@mail.nih.gov